Morishita Jintan Enters Drug Mail Order Business
This article was originally published in PharmAsia News
Executive Summary
Osaka-based health foods mail order company Morishita Jintan will set up Jintan Pharmacy Feb. 11 to sell constipation drug Bifina by mail order. The company plans to expand product lines to include treatments for metabolism disorders and mental health care. Produced and marketed by Morishita Jintan and distributed by Tanabe Mitsubishi, Bifina combines herbal extract calcium sennosides and bifidobacteria. (Click for more-Japanese language
You may also be interested in...
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.
Taro Agrees $36m Securities Settlement Over US Price-Fixing Claims
Sun’s Taro subsidiary is looking to move forward with an eight-figure settlement deal in the US, after plaintiffs including a firefighters’ pension fund accused the firm of misleading investors via its involvement in generic price fixing, leading to a fall in the price of its securities.